Back to insights
Category
Industry Insights
Market trends, insights, and analysis for the chemical industry.
Article29 min read
After a Patent Expires, What Actually Stops Anyone From Making the Molecule?
The FDA still keeps a list of drugs that are off patent, off exclusivity, and have no generic at all. Novo Nordisk owns semaglutide outright and still paid $11 billion for filling capacity. Japan restricted three chemicals to Korea in 2019 and only one of them actually bit. This piece gathers the evidence from pharmaceuticals, agrochemicals, and electronic materials into one framework: the Reaction Interface Economy.
Article10 min read
Why Do Global Petrochemical Intermediate Prices Always Trace Back to Crude Oil Benchmarks?
Crude oil doesn't set petrochemical prices directly — it anchors a chain that runs through refinery economics, the choice between naphtha, ethane, and coal-based feedstock, cracker margins, and market repricing. This piece traces why ethylene reacts to Brent within days while bisphenol A and epoxy resin lag by weeks, why US shale ethane and Chinese coal-to-olefins routes are decoupling from Brent, and why the deepest competition in petrochemicals runs between carbon resources, not molecules.
Article14 min read
Why Do Almost All the World's Laundry Detergents Rely on the Same Chemical Intermediate?
Modern detergents don't compete on cleaning power alone — they compete on what happens after they leave the drain. This piece traces how one carbon chain's shape triggered a global regulatory shift, why LAB plants are secretly refinery chemistry, why a process everyone calls dangerous has run for sixty years, and why only a handful of companies can make it well.
Article11 min read
Why Did 20th-Century Oil Mean "Reaching" the Underground, While the 21st Century Means "Controlling" It?
Twenty years ago, "oilfield chemicals" was a sufficient category, because the subsurface served almost one purpose: oil and gas. Today, the same underground space holds CO2, hydrogen, geothermal heat, and lithium from brine — the old label no longer explains reality. This piece names a broader frame: Subsurface Chemical Infrastructure.
Article10 min read
Why Doesn't the Chemical Industry Actually Sell Molecules?
A synthesis route becomes public the moment its patent expires — but most of what actually decides whether a molecule can be made reliably, safely, and cheaply never gets written down. Four layers trace the gap between a public route and a defensible manufacturing capability: process development, scale-up, accumulated tacit experience, and where AI does and doesn't fit.
Article12 min read
Why Are High-Performance Polymers Replacing Metal?
The modern materials revolution isn't a search for the best material — it's a search for one with no weak dimension. From molecular design to aerospace, AI, and clean energy, this piece traces why metal is losing ground, and why only a handful of companies can actually manufacture the polymers taking its place.
Article15 min read
Why Can Only a Handful of Companies Make Top-Tier OLED Emitter Materials?
The hardest part of making OLED was never getting a molecule to glow — it's controlling electrons: where electrons and holes go, where excitons form, and how to keep that from running wild over tens of thousands of hours. This piece walks through seven barriers to answer why so few companies can pull it off.
Article11 min read
What's Hardest to Get After a Patent Expires Isn't the Patent — It's the Intermediate
Cyantraniliprole, pinoxaden, and sulfoxaflor all lose patent protection between 2026 and 2027. The common assumption is that any manufacturer with capacity can now copy the molecule. What usually decides whether that actually happens is whether the key intermediates are available at all.
Article21 min read
Why the AI Boom Is Also a Chemistry Boom: Inside the Ultra-High-Purity Electronic Chemicals Supply Chain Behind HBM, CoWoS, and Electronic-Grade HF
An AI chip isn't just bigger than an ordinary chip — it passes through more lithography, etch, clean, and polish cycles, each consuming ultra-high-purity photoresist, CMP slurry, electronic-grade HF, sulfuric acid, and PGMEA at parts-per-trillion purity. A fact-based map of why this supply chain is short, hard to switch suppliers on, and now visibly tightening.
Article19 min read
Why Is Suzuki Coupling Still the Core Platform Reaction for Modern API Synthesis, Four Decades Later?
Suzuki-Miyaura coupling has quietly become the default platform reaction in small-molecule API manufacturing, shaping which building blocks get sourced and whether a route can scale to metric tons. A fact-based look at why one reaction, from Losartan to Sotorasib, still anchors modern pharmaceutical supply chains four decades after its discovery.
Article13 min read
Why Does One Chemical Intermediate End Up in Dozens of Pesticides? Inside the Reaction Interface Economy
A single pyridine intermediate feeds four different neonicotinoid insecticides. A single pyrazole acid feeds a whole family of SDHI fungicides. This isn't coincidence — it's the Reaction Interface Economy, the organizing logic behind modern agrochemical R&D and its supply chain.
ArticleChemAbout Editorial Team13 min read
Why Fluorine Chemistry Has Become a Foundation of Modern Industry: From PFAS Regulation to Next-Generation Drugs and Semiconductor Materials
Fluorine is not an ordinary element but a tuning knob for molecular performance - one element that underpins drugs, agrochemicals, semiconductors, and batteries at once. This deep dive traces the C-F bond's performance leverage, why fluorine dominates modern drug design, why NF3/CF4/SF6 are irreplaceable in chip etching, the fluorite-to-HF value chain that four industries share, and why regulating PFAS (a structural, not toxicological, definition) is not the same as opposing fluorine chemistry. Every key fact cited to a primary source. Not compliance advice.